CFT-27796

N/A

Report date: 2025/09/04 10:36:30
NME

Base Information

Drug NameCFT-27796
Drug Alias NameRET tyrosine kinase inhibitors (C4 Therapeutics)CFT-27796
ClassificationOther
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC4 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesC4 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A